Articles
Latest Articles
Commentaries
Deals
Distillery
Emerging Companies
Finance
Politics, Policy & Law
Product Development
Regulation
Targets & Mechanisms
Tools & Techniques
Current Editions
Search Archives
BCIQ
Company Profiles
Target Profiles
Product Profiles
Conferences
China Healthcare Summit
Bio€quity Europe
White Papers
Free Trial
/
Subscribe
Sign In
more_vert
Biocentury
Company Profiles
Target Profiles
Product Profiles
Free Trial Information
Export Pdf
Overview
Pipeline
Deals
Financings
Earnings Summary
Stock Summary
Articles
BioCentury
|
Jan 12, 2018
Financial News
Braeburn raises $110M mezzanine round
...Princeton, N.J.) closed on Jan. 10 a $110 million mezzanine financing led by new investor
Wellington Capital Management
...
Read More
BioCentury
|
Jan 10, 2018
Financial News
Braeburn raises $110M in mezzanine round
...Inc. (Princeton, N.J.) said it closed a $110 million mezzanine financing led by new investor
Wellington Capital Management
...
Read More
BioCentury
|
Jun 27, 2016
Financial News
CRISPR Therapeutics financial update
...million. Franklin Templeton Investments; New Leaf Venture Partners; funds advised by Clough Capital Partners and
Wellington Capital Management
...
Read More
BioCentury
|
Jun 25, 2016
Financial News
CRISPR Therapeutics adds $38M to series B round
...including Franklin Templeton Investments, New Leaf Venture Partners, funds advised by Clough Capital Partners and
Wellington Capital Management
...
Read More
BioCentury
|
Feb 16, 1999
Finance
Britain's ray of sunshine
...up C$0.62, giving the company a market cap of C$47 million (US$31.5 million). Buyside watch
Wellington Capital Management
...
Read More
Items per page:
10
1 - 5 of 5
BioCentury
|
Jan 12, 2018
Financial News
Braeburn raises $110M mezzanine round
...Princeton, N.J.) closed on Jan. 10 a $110 million mezzanine financing led by new investor
Wellington Capital Management
...
Read More
BioCentury
|
Jan 10, 2018
Financial News
Braeburn raises $110M in mezzanine round
...Inc. (Princeton, N.J.) said it closed a $110 million mezzanine financing led by new investor
Wellington Capital Management
...
Read More
BioCentury
|
Jun 27, 2016
Financial News
CRISPR Therapeutics financial update
...million. Franklin Templeton Investments; New Leaf Venture Partners; funds advised by Clough Capital Partners and
Wellington Capital Management
...
Read More
BioCentury
|
Jun 25, 2016
Financial News
CRISPR Therapeutics adds $38M to series B round
...including Franklin Templeton Investments, New Leaf Venture Partners, funds advised by Clough Capital Partners and
Wellington Capital Management
...
Read More
BioCentury
|
Feb 16, 1999
Finance
Britain's ray of sunshine
...up C$0.62, giving the company a market cap of C$47 million (US$31.5 million). Buyside watch
Wellington Capital Management
...
Read More
Items per page:
10
1 - 5 of 5
Previous page
Next page